血液灌流对IL-6、TNF-α、CRP的影响

被引：22

作者：

赵慧媛

李荣山

邵珊

程丽娟

高仁义

李建平

张渝

李元红

成秀芬

机构：

[1] 山西医科大学第二临床医学院

[2] 山西医科大学第二临床医学院研究生太原山西大同第五人民医院肾内科

[3] 太原

来源：

中国血液净化 | 2005年 / 10期

关键词：

TNF; CRP; IL-6; 血液灌流; 维持性血液透析患者;

D O I：

暂无

中图分类号：

R459.5 [透析疗法];

学科分类号：

100215 ;

摘要：

引用

页码：566 / 568

页数：3

共 8 条

[1] The effects of haemodialysis and peritoneal dialysis on serum lipoprotein(a) and C-reactive protein levels [J].

Borazan, A ;

Üstün, H ;

Yilmaz, A .

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2003, 31 (05) :378-383

[2]

Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy[J] . Michael Danielski,T.Alp Ikizler,Ellen McMonagle,Jane Conner Kane,Lara Pupim,Jason Morrow,Jonathan Himmelfarb.American Journal of Kidney Diseases . 2003 (2)

[3]

Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate/lactate-based peritoneal dialysis solutions[J] . LA Cooker,P Luneburg,CJ Holmes,S Jones,N Topley.Peritoneal Dialysis International . 2001 (Supp)

[4] High-volume haemofiltration in human septic shock [J].

Cole, L ;

Bellomo, R ;

Journois, D ;

Davenport, P ;

Baldwin, I ;

Tipping, P .

INTENSIVE CARE MEDICINE, 2001, 27 (06) :978-986

[5] Inflammation is associated with carotid atherosclerosis in dialysis patients [J].

Zoccali, C ;

Benedetto, FA ;

Mallamaci, F ;

Tripepi, G ;

Fermo, I ;

Focà, A ;

Paroni, R ;

Malatino, LS .

JOURNAL OF HYPERTENSION, 2000, 18 (09) :1207-1213

[6] Interleukin-6 gene expression in peripheral blood mononuclear cells from patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis [J].

Takahashi, T ;

Kubota, M ;

Nakamura, T ;

Ebihara, I ;

Koide, H .

RENAL FAILURE, 2000, 22 (03) :345-354

[7]

Anorexigen （TNF-alpha , cholecystokini）and orexigen （neuropeptide Y）plasma levels in peritoneal dialysis （PD） patients:their relationship with nutritional parameters. Aguilera A,Codoceo P,Selgas P, et al. Nephrology Dialysis Transplantation . 1998

[8]

Monocyte/macrophage response to β2-microglobulin modified with advanced glycation end products. Miyata T, Iida Y, Ueda Y et al. Kidney International . 1996

← 1 →